<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12915</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12915</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Сочетанное атеросклеротическое поражение сонных артерий и артерий нижних конечностей у больных сахарным диабетом 2 типа: факторы риска и биомаркеры</article-title><trans-title-group xml:lang="en"><trans-title>Association of carotid atherosclerosis and peripheral artery disease in patients with type 2 diabetes: risk factors and biomarkers</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8629-7030</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королева</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Koroleva</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Королева Елена Анатольевна - кандидат медицинских наук, старший научный струдник ; Scopus Author ID: 55522435000.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Elena A. Koroleva - MD, PhD, senior research associate. ; Scopus Author ID: 55522435000</p><p>Novosibirsk</p></bio><email xlink:type="simple">ekoro@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6861-7152</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хапаев</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Khapaev</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хапаев Рустам Сагитович - кандидат медицинских наук, старший научный струдник</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Rustam S. Khapaev - MD, PhD, senior research associate.</p><p>Novosibirsk</p></bio><email xlink:type="simple">rskhapaev@outlook.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4897-8676</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лыков</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lykov</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лыков Александр Петрович, кандидат медицинских наук, ведущий научный струдник; Scopus Author ID: 7005078523</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Alexander P. Lykov - MD, PhD, leading research associate; Scopus Author ID: 7005078523.</p><p>Novosibirsk</p></bio><email xlink:type="simple">aplykov2@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3502-5892</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корбут</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Korbut</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корбут Антон Иванович - кандидат медицинских наук, старший научный струдник; Scopus Author ID: 57151138800.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Anton I. Korbut - MD, PhD, senior research associate; Scopus Author ID: 57151138800</p><p>Novosibirsk</p></bio><email xlink:type="simple">anton.korbut@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5407-8722</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Климонтов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimontov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Климонтов Вадим Валерьевич - доктор медицинских наук, профессор; Researcher ID: R-7689-2017; Scopus Author ID: 8295977000.</p><p>630060, Новосибирск, ул. Тимакова, д. 2</p></bio><bio xml:lang="en"><p>Vadim V. Klimontov - MD, PhD, Professor; Researcher ID: R-7689-2017; Scopus Author ID: 8295977000</p><p>2 Timakov street, 630060 Novosibirsk</p></bio><email xlink:type="simple">klimontov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт клинической и экспериментальной лимфологии — филиал ФГБНУ Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Clinical and Experimental Lymphology — Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL — Branch of IC&amp;G SB RAS)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>05</month><year>2023</year></pub-date><volume>26</volume><issue>2</issue><fpage>172</fpage><lpage>181</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Королева Е.А., Хапаев Р.С., Лыков А.П., Корбут А.И., Климонтов В.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Королева Е.А., Хапаев Р.С., Лыков А.П., Корбут А.И., Климонтов В.В.</copyright-holder><copyright-holder xml:lang="en">Koroleva E.A., Khapaev R.S., Lykov A.P., Korbut A.I., Klimontov V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12915">https://www.dia-endojournals.ru/jour/article/view/12915</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Атеросклероз сонных артерий (СА) и артерий нижних конечностей (АНК) — распространенные и потенциально жизнеугрожающие коморбидные состояния при сахарном диабете (СД).</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Определить факторы риска и биомаркеры сочетанного атеросклеротического поражения СА и АНК у больных СД 2 типа (СД2).</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. Проведено одноцентровое поперечное сравнительное исследование. В исследование включен 391 больной. Всем пациентам выполнены ультразвуковое дуплексное сканирование СА и АНК, скрининг/мониторинг осложнений диабета и ассоциированных состояний, исследованы параметры гликемического контроля, биохимические параметры, показатели гемостаза. В сыворотке крови с помощью иммуноферментного анализа определяли факторы, вовлеченные в ремоделирование сосудистой стенки: кальпонин-1, релаксин, L-цитруллин, матриксные металлопротеиназы-2 и -3.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Признаки атеросклероза СА и АНК выявлены у 330 и 187 больных соответственно. У 178 пациентов выявлено сочетание атеросклероза СА и АНК. Риск сочетанного поражения СА и АНК был выше у больных с диабетической ретинопатией (ОШ=2,57; р&lt;0,001), хронической болезнью почек (ОШ=4,48; р&lt;0,001), инфарктом миокарда (ОШ=5,09; р&lt;0,001), коронарной реваскуляризацией (ОШ=4,31; р&lt;0,001) или острым нарушением мозгового кровообращения (ОШ=3,07; р&lt;0,001) в анамнезе. В ROC-анализе факторами риска сочетанного атеросклероза СА и АНК являлись: возраст ≥65,5 года (ОШ=3,43; р&lt;0,001), соотношение окружность талии/окружность бедер (ОТ/ОБ) ≥0,967 (ОШ=3,01; р=0,001), длительность СД ≥12,5 года (ОШ=3,7; р&lt;0,001), длительность инсулинотерапии ≥4,5 года (ОШ=3,05; р&lt;0,001), длительность артериальной гипертензии ≥16,5 года (ОШ=1,98; р=0,002), уровень L-цитруллина сыворотки ≥68 мкмоль/л (ОШ=3,82; р=0,003), средняя амплитуда колебаний гликемии (MAGE) ≥3,72 ммоль/л (ОШ=1,79; р=0,006). В многофакторном логистическом регрессионном анализе независимыми факторами риска атеросклероза СА и АНК были возраст (р=0,005), длительность СД (р=0,0003) и ОТ/ОБ (р=0,004).</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Сочетанное поражение СА и АНК у больных СД2 ассоциировано с возрастом, длительностью СД, абдоминальным ожирением, микрососудистыми и макрососудистыми осложнениями, вариабельностью гликемии, высоким уровнем L-цитруллина.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Carotid atherosclerosis (CA) and lower extremity peripheral artery disease (PAD) is a common and potentially life-threatening comorbidity in diabetes.</p></sec><sec><title>AIM</title><p>AIM: to determine risk factors and biomarkers of the association of CA and PAD in patients with type 2 diabetes.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: A single-center cross-sectional comparative study was carried out. Three hundred ninety one patients with type 2 diabetes were included. Duplex ultrasound of carotid and low limb arteries, screening/monitoring of diabetic complications and associated diseases, and assessment of glycemic control, biochemical and coagulation parameters were performed. Factors involved in vascular wall remodeling, including calponin-1, relaxin, L-citrulline, matrix metalloproteinase-2 and -3, were measured in blood serum by ELISA.</p></sec><sec><title>RESULTS</title><p>RESULTS: The signs of CA and PAD were observed in 330 and 187 patients respectively. In 178 patients, both CA and PAD were revealed. The risk of combined involvement of carotid and lower extremity arteries was higher in patients with diabetic retinopathy (OR=2.57, p&lt;0.001), chronic kidney disease (OR=4.48, p&lt;0.001), history of myocardial infarction (OR=5.09, p&lt;0.001), coronary revascularization (OR=4.31, p&lt;0.001) or cerebrovascular accident (OR=3.07, p&lt;0.001). In ROC-analysis, age ≥65.5 years (OR=3.43, p&lt;0.001), waist-to-hip ratio ≥0.967 (OR=3.01, p=0.001), diabetes duration ≥12.5 years (OR=3.7, p&lt;0.001), duration of insulin therapy ≥4.5 years (OR=3.05, p&lt;0.001), duration of arterial hypertension ≥16.5 years (OR=1.98, p=0.002), serum L-citrulline ≥68 µmol/l (OR=3.82, p=0.003), and mean amplitude of glucose excursions ≥3.72 mmol/l (OR=1.79, p=0.006) were the risk factors for atherosclerosis of two vascular beds. In multivariate logistic regression analysis, age, diabetes duration and waist-to-hip ratio were independent risk factors for association of CA and PAD (p=0.005, p=0.0003, and p=0.004 respectively).</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: In subjects with type 2 diabetes, carotid and lower extremity atherosclerotic disease is associated with age, diabetes duration, abdominal obesity, microvascular and macrovascular complications, glucose variability, and high serum levels of L-citrulline.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 2 типа</kwd><kwd>атеросклероз сонных артерий</kwd><kwd>макроангиопатия нижних конечностей</kwd><kwd>фактор  риска</kwd><kwd>биомаркер</kwd></kwd-group><kwd-group xml:lang="en"><kwd>type 2 diabetes</kwd><kwd>carotid atherosclerosis</kwd><kwd>peripheral artery disease</kwd><kwd>risk factor</kwd><kwd>biomarker</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет средств государственного задания НИИКЭЛ — филиал ИЦиГ СО РАН</funding-statement><funding-statement xml:lang="en">Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL – Branch of IC&amp;G SB RAS), Novosibirsk, Russia</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808-1817. doi: https://doi.org/10.1161/ATVBAHA.120.314595</mixed-citation><mixed-citation xml:lang="en">Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808-1817. doi: https://doi.org/10.1161/ATVBAHA.120.314595</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics — 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209. doi: https://doi.org/10.1161/CIR.0b013e3182009701 Erratum in: Circulation. 2011;123(6):e240. Erratum in: Circulation. 2011;124(16):e426.</mixed-citation><mixed-citation xml:lang="en">Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics — 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209. doi: https://doi.org/10.1161/CIR.0b013e3182009701 Erratum in: Circulation. 2011;123(6):e240. Erratum in: Circulation. 2011;124(16):e426.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hoke, M., Schillinger, M., Minar, E. et al. Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus. Cardiovasc Diabetol. 2019;18:90. doi: https://doi.org/10.1186/s12933-019-0895-0</mixed-citation><mixed-citation xml:lang="en">Hoke, M., Schillinger, M., Minar, E. et al. Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus. Cardiovasc Diabetol. 2019;18:90. doi: https://doi.org/10.1186/s12933-019-0895-0</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Malmstedt J, Kärvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol. 2015;14:93. doi: https://doi.org/10.1186/s12933-015-0257-5</mixed-citation><mixed-citation xml:lang="en">Malmstedt J, Kärvestedt L, Swedenborg J, Brismar K. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol. 2015;14:93. doi: https://doi.org/10.1186/s12933-015-0257-5</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nativel M, Potier L, Alexandre L, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018;17(1):138. doi: https://doi.org/10.1186/s12933-018-0781-1</mixed-citation><mixed-citation xml:lang="en">Nativel M, Potier L, Alexandre L, et al. Lower extremity arterial disease in patients with diabetes: a contemporary narrative review. Cardiovasc Diabetol. 2018;17(1):138. doi: https://doi.org/10.1186/s12933-018-0781-1</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 9-й вып. // Сахарный диабет. — 2019. — Т. 22. — Прил. 1S1. — С. 1-144. doi: https://doi.org/10.14341/DM221S1</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Ed. Dedov II, Shestakova MV, Mayorov AYu. 9th ed. Diabetes mellitus. 2019;22(1S1):1-144. (In Russ.). doi: https://doi.org/10.14341/DM221S1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu R, Jin J.-P. Calponin Isoforms CNN 1, CNN 2 and CNN 3: Regulators for Actin Cytoskeleton Functions in Smooth Muscle and Non-Muscle Cells. Gene 2016;585:143-153. doi: https://doi.org/10.1016/j.gene.2016.02.040</mixed-citation><mixed-citation xml:lang="en">Liu R, Jin J.-P. Calponin Isoforms CNN 1, CNN 2 and CNN 3: Regulators for Actin Cytoskeleton Functions in Smooth Muscle and Non-Muscle Cells. Gene 2016;585:143-153. doi: https://doi.org/10.1016/j.gene.2016.02.040</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Teichman SL, Unemori E, Teerlink JR, et al. Relaxin: Review of Biology and Potential Role in Treating Heart Failure. Curr. Heart Fail. Rep. 2010;7:75-82. doi: https://doi.org/10.1007/s11897-010-0010-z</mixed-citation><mixed-citation xml:lang="en">Teichman SL, Unemori E, Teerlink JR, et al. Relaxin: Review of Biology and Potential Role in Treating Heart Failure. Curr. Heart Fail. Rep. 2010;7:75-82. doi: https://doi.org/10.1007/s11897-010-0010-z</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Allerton T, Proctor D, Stephens J, et al. L-Citrulline Supplementation: Impact on Cardiometabolic Health. Nutrients 2018;10:921. doi: https://doi.org/10.3390/nu10070921</mixed-citation><mixed-citation xml:lang="en">Allerton T, Proctor D, Stephens J, et al. L-Citrulline Supplementation: Impact on Cardiometabolic Health. Nutrients 2018;10:921. doi: https://doi.org/10.3390/nu10070921</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vacek T, Rahman S, Yu S, et al. Matrix Metalloproteinases in Atherosclerosis: Role of Nitric Oxide, Hydrogen Sulfide, Homocysteine, and Polymorphisms. Vasc. Health Risk Manag. 2015;11:173. doi: https://doi.org/10.2147/VHRM.S68415</mixed-citation><mixed-citation xml:lang="en">Vacek T, Rahman S, Yu S, et al. Matrix Metalloproteinases in Atherosclerosis: Role of Nitric Oxide, Hydrogen Sulfide, Homocysteine, and Polymorphisms. Vasc. Health Risk Manag. 2015;11:173. doi: https://doi.org/10.2147/VHRM.S68415</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intimamedia thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6. doi: https://doi.org/10.1159/000343145</mixed-citation><mixed-citation xml:lang="en">Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intimamedia thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6. doi: https://doi.org/10.1159/000343145</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lim TK, Lim E, Dwivedi G, et al. Normal value of carotid intima-media thickness--a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr. 2008;21(2):112-6. doi: https://doi.org/10.1016/j.echo.2007.05.002</mixed-citation><mixed-citation xml:lang="en">Lim TK, Lim E, Dwivedi G, et al. Normal value of carotid intima-media thickness--a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr. 2008;21(2):112-6. doi: https://doi.org/10.1016/j.echo.2007.05.002</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim ES, Sharma AM, Scissons R, et al. Interpretation of peripheral arterial and venous Doppler waveforms: A consensus statement from the Society for Vascular Medicine and Society for Vascular Ultrasound. Vasc Med. 2020;25(5):484-506. doi: https://doi.org/10.1177/1358863X20937665</mixed-citation><mixed-citation xml:lang="en">Kim ES, Sharma AM, Scissons R, et al. Interpretation of peripheral arterial and venous Doppler waveforms: A consensus statement from the Society for Vascular Medicine and Society for Vascular Ultrasound. Vasc Med. 2020;25(5):484-506. doi: https://doi.org/10.1177/1358863X20937665</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hill N, Nick S, Choudhary P, et al. Normal Reference Range For Mean Tissue Glucose And Glycemic Variability Derived From Continuous Glucose Monitoring For Subjects Without Diabetes In Different Ethnic Groups. Diabetes Technol Ther. 2011;13(9):921-928. doi: https://doi.org/10.1089/Dia.2010.0247</mixed-citation><mixed-citation xml:lang="en">Hill N, Nick S, Choudhary P, et al. Normal Reference Range For Mean Tissue Glucose And Glycemic Variability Derived From Continuous Glucose Monitoring For Subjects Without Diabetes In Different Ethnic Groups. Diabetes Technol Ther. 2011;13(9):921-928. doi: https://doi.org/10.1089/Dia.2010.0247</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cardoso CRL, Marques CEC, Leite NC, Salles GF. Factors Associated with Carotid Intima-Media Thickness and Carotid Plaques in Type 2 Diabetic Patients. J Hypertens. 2012;30(5):940–947. doi: https://doi.org/10.1097/HJH.0b013e328352aba6</mixed-citation><mixed-citation xml:lang="en">Cardoso CRL, Marques CEC, Leite NC, Salles GF. Factors Associated with Carotid Intima-Media Thickness and Carotid Plaques in Type 2 Diabetic Patients. J Hypertens. 2012;30(5):940–947. doi: https://doi.org/10.1097/HJH.0b013e328352aba6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan C, Lai CWK, Chan LWC, Chow M, Law HKW, Ying M. Cumulative Effects of Hypertension, Dyslipidemia, and Chronic Kidney Disease on Carotid Atherosclerosis in Chinese Patients with Type 2 Diabetes Mellitus. J Diabetes Res. 2014;2014:179686. doi: https://doi.org/10.1155/2014/179686</mixed-citation><mixed-citation xml:lang="en">Yuan C, Lai CWK, Chan LWC, Chow M, Law HKW, Ying M. Cumulative Effects of Hypertension, Dyslipidemia, and Chronic Kidney Disease on Carotid Atherosclerosis in Chinese Patients with Type 2 Diabetes Mellitus. J Diabetes Res. 2014;2014:179686. doi: https://doi.org/10.1155/2014/179686</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y-Y, Qiu H.-M, Yang Y, Han Y.-Y. Analysis of Risk Factors for Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus in Western China Assessed by Logistic Regression Combined with a Decision Tree Model. Diabetol Metab Syndr. 2020;12:8. doi: https://doi.org/10.1186/s13098-020-0517-8</mixed-citation><mixed-citation xml:lang="en">Zhou Y-Y, Qiu H.-M, Yang Y, Han Y.-Y. Analysis of Risk Factors for Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus in Western China Assessed by Logistic Regression Combined with a Decision Tree Model. Diabetol Metab Syndr. 2020;12:8. doi: https://doi.org/10.1186/s13098-020-0517-8</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Klimontov VV, Koroleva EA, Khapaev RS, Korbut AI, Lykov AP. Carotid Artery Disease in Subjects with Type 2 Diabetes: Risk Factors and Biomarkers. J Clin Med. 2021;11(1):72. doi: https://doi.org/10.3390/jcm11010072</mixed-citation><mixed-citation xml:lang="en">Klimontov VV, Koroleva EA, Khapaev RS, Korbut AI, Lykov AP. Carotid Artery Disease in Subjects with Type 2 Diabetes: Risk Factors and Biomarkers. J Clin Med. 2021;11(1):72. doi: https://doi.org/10.3390/jcm11010072</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Викулова О.К., и др. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. // Сахарный диабет. — 2019. — T. 22. — 2S. — P. 4-61. doi: https://doi.org/10.14341/DM12208</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Vikulova OK, et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019;22(2S):4-61. (In Russ.). doi: https://doi.org/10.14341/DM12208</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Eto F, Washida K, Matsubara M, et al. Glucose Fluctuation and Severe Internal Carotid Artery Siphon Stenosis in Type 2 Diabetes Patients. Nutrients. 2021;13(7):2379. doi: https://doi.org/10.3390/nu13072379</mixed-citation><mixed-citation xml:lang="en">Eto F, Washida K, Matsubara M, et al. Glucose Fluctuation and Severe Internal Carotid Artery Siphon Stenosis in Type 2 Diabetes Patients. Nutrients. 2021;13(7):2379. doi: https://doi.org/10.3390/nu13072379</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Климонтов В.В. Влияние вариабельности гликемии на риск развития сердечно-сосудистых осложнений при сахарном диабете // Кардиология. — 2018. — Т. 58. — №10. — С. 80-87. doi: https://doi.org/10.18087/cardio.2018.10.10152</mixed-citation><mixed-citation xml:lang="en">Klimontov VV. Impact of Glycemic Variability on Cardiovascular Risk in Diabetes. Kardiologiia. 2018;(10):80-87. (In Russ.)]. doi: https://doi.org/10.18087/cardio.2018.10.10152</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Klimontov VV, Saik OV, Korbut AI. Glucose Variability: How Does It Work? Int J Mol Sci. 2021;22(15):7783. doi: https://doi.org/10.3390/ijms22157783</mixed-citation><mixed-citation xml:lang="en">Klimontov VV, Saik OV, Korbut AI. Glucose Variability: How Does It Work? Int J Mol Sci. 2021;22(15):7783. doi: https://doi.org/10.3390/ijms22157783</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Magnusson M, Wang T, Hedblad B, et al. High Levels of Arginine, Citrulline and ADMA Are Independent Predictors of Cardiovascular Disease. Eur Heart J. 2013;34:P5687–P5687. doi: https://doi.org/10.1093/eurheartj/eht310.P5687</mixed-citation><mixed-citation xml:lang="en">Magnusson M, Wang T, Hedblad B, et al. High Levels of Arginine, Citrulline and ADMA Are Independent Predictors of Cardiovascular Disease. Eur Heart J. 2013;34:P5687–P5687. doi: https://doi.org/10.1093/eurheartj/eht310.P5687</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Aguayo E, Martínez-Sánchez A, Fernández-Lobato B, Alacid F. L-Citrulline: A Non-Essential Amino Acid with Important Roles in Human Health. Appl. Sci. 2021;11:3293. doi: https://doi.org/10.3390/app11073293</mixed-citation><mixed-citation xml:lang="en">Aguayo E, Martínez-Sánchez A, Fernández-Lobato B, Alacid F. L-Citrulline: A Non-Essential Amino Acid with Important Roles in Human Health. Appl. Sci. 2021;11:3293. doi: https://doi.org/10.3390/app11073293</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
